# Topical Oestrogens and Antimuscarinics In The Treatment Of Detrusor Overactivity

> **NCT00648310** · PHASE2,PHASE3 · COMPLETED · sponsor: **Università degli Studi dell'Insubria**

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** Tolterodine 4 mg
- **DRUG:** arm 2: Tolterodine 4 mg + local oestrogens once daily for 12 weeks

## Key facts

- **NCT ID:** NCT00648310
- **Lead sponsor:** Università degli Studi dell'Insubria
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** — (—)
- **Last updated:** 2008-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00648310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00648310, "Topical Oestrogens and Antimuscarinics In The Treatment Of Detrusor Overactivity". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00648310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*